DERIVATIVES OF N-(ARYLAMINO) SULFONAMIDES AS INHIBITORS OF MEK
申请人:Maderna Andreas
公开号:US20080058340A1
公开(公告)日:2008-03-06
This invention concerns N-(2-arylamino) aryl sulfonamides, which are inhibitors of MEK and are useful in treatment of cancer and other hyperproliferative diseases.
DERIVATIVES OF N-(ARYLAMINO) SULFONAMIDES INCLUDING POLYMORPHS AS INHIBITORS OF MEK AS WELL AS COMPOSITIONS, METHODS OF USE AND METHODS FOR PREPARING THE SAME
申请人:Vernier Jean-Michel
公开号:US20110060049A1
公开(公告)日:2011-03-10
This invention concerns N-(2-arylamino) aryl sulfonamide compounds which are inhibitors of MEK including crystalline polymorphic forms which exhibit a specific powder x-ray diffraction profile and/or a specific differential scanning calorimetry profile. This invention also concerns pharmaceutical compositions comprising the compounds described herein and methods of use of the compounds and compositions described herein, including the use in the treatment and/or prevention of cancer, hyperproliferative diseases and inflammatory conditions. The invention also concerns methods of making the compounds and compositions described herein.
Derivatives of N-(arylamino) sulfonamides as inhibitors of MEK
申请人:Ardea Biosciences
公开号:US07759518B2
公开(公告)日:2010-07-20
This invention concerns N-(2-arylamino)aryl sulfonamides, which are inhibitors of MEK and are useful in treatment of cancer and other hyperproliferative diseases.
NOVEL MEK INHIBITORS USEFUL IN THE TREATMENT OF DISEASES
申请人:Khire Uday R.
公开号:US20120208859A1
公开(公告)日:2012-08-16
The invention pertains to compound of Formula (I) wherein X, Y, Z, R
1
, R
2
, R
3
, R
4
, A and A′ are as described hereinabove. Formula (I) and (II) compounds can be used in pharmaceutical compositions, useful for the treatment of diseases.
DERIVATIVES OF N-(ARYLAMINO)SULFONAMIDES AS INHIBITORS OF MEK
申请人:MADERNA Andreas
公开号:US20120022076A1
公开(公告)日:2012-01-26
This invention concerns N-(2-arylamino)aryl sulfonamides, which are inhibitors of MEK and are useful in treatment of cancer and other hyperproliferative diseases.